Printer Friendly

ESCAGENETICS COMPLETES THE PLACEMENT OF 1.8 MILLION SHARES OF COMMON STOCK

 SAN CARLOS, Calif., Oct. 11 /PRNewswire/ -- ESCAgenetics Corp. (AMEX: ESN) today announced that it has completed the offering of 1.8 million shares of the company's common stock for the aggregate proceeds of $8.1 million. The shares were offered by Reich & Co. Inc., New York City, the company's investment banker.
 ESCAgenetics Corp. is a publicly traded company that develops and produces high-value, plant-derived products for the pharmaceutical and food processing industries.
 -0- 10/11/93
 /CONTACT: Raymond J. Moshy, president and chief executive officer, or William J. Koenig, executive vice president, 415-595-5335, both of ESCAgenetics Corp./
 (ESN)


CO: ESCAgenetics Corp. ST: California IN: MTC SU: OFR

LH-TM -- SF007 -- 0746 10/11/93 15:07 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 11, 1993
Words:116
Previous Article:SHARED MEDICAL SYSTEMS ISSUES ANNOUNCEMENT
Next Article:MERRY LAND & INVESTMENT COMPANY REPORTS RECORD EARNINGS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters